The Manufacturers Life Insurance Company Boosts Stake in Option Care Health, Inc. (NASDAQ:OPCH)

The Manufacturers Life Insurance Company raised its position in Option Care Health, Inc. (NASDAQ:OPCHFree Report) by 0.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,386,537 shares of the company’s stock after purchasing an additional 10,056 shares during the quarter. The Manufacturers Life Insurance Company owned 0.78% of Option Care Health worth $46,712,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Victory Capital Management Inc. increased its position in shares of Option Care Health by 41.2% during the third quarter. Victory Capital Management Inc. now owns 72,177 shares of the company’s stock worth $2,335,000 after acquiring an additional 21,065 shares during the period. New York State Common Retirement Fund increased its position in shares of Option Care Health by 289.5% during the third quarter. New York State Common Retirement Fund now owns 381,847 shares of the company’s stock worth $12,353,000 after acquiring an additional 283,818 shares during the period. Oppenheimer Asset Management Inc. purchased a new position in shares of Option Care Health during the third quarter worth approximately $474,000. New York Life Investment Management LLC increased its position in shares of Option Care Health by 111.9% during the third quarter. New York Life Investment Management LLC now owns 19,093 shares of the company’s stock worth $618,000 after acquiring an additional 10,083 shares during the period. Finally, Amalgamated Bank increased its position in shares of Option Care Health by 4.1% during the third quarter. Amalgamated Bank now owns 113,237 shares of the company’s stock worth $3,663,000 after acquiring an additional 4,495 shares during the period. 98.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

OPCH has been the topic of a number of research reports. Barrington Research reaffirmed an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a research report on Wednesday, April 24th. Jefferies Financial Group lifted their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a report on Monday, March 4th.

Check Out Our Latest Stock Report on Option Care Health

Option Care Health Stock Performance

Shares of OPCH stock opened at $29.69 on Thursday. The firm has a market cap of $5.16 billion, a price-to-earnings ratio of 19.53, a PEG ratio of 1.47 and a beta of 1.31. The company’s 50 day moving average is $30.44 and its 200 day moving average is $31.48. The company has a quick ratio of 1.39, a current ratio of 1.77 and a debt-to-equity ratio of 0.74. Option Care Health, Inc. has a 52-week low of $26.17 and a 52-week high of $35.74.

Option Care Health (NASDAQ:OPCHGet Free Report) last issued its quarterly earnings data on Tuesday, April 23rd. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.04. The company had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.10 billion. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. Option Care Health’s revenue was up 12.8% compared to the same quarter last year. During the same period last year, the company posted $0.21 earnings per share. On average, sell-side analysts anticipate that Option Care Health, Inc. will post 1.19 EPS for the current fiscal year.

About Option Care Health

(Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

See Also

Institutional Ownership by Quarter for Option Care Health (NASDAQ:OPCH)

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.